Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Former FDA director joins ISPE

This article was originally published in Scrip

Executive Summary

The International Society for Pharmaceutical Engineering (ISPE), a not-for-profit association of 24,000 technical professionals working in the manufacturing and drug development sectors of the pharmaceutical industry, has named Anthony Celeste North America Regulatory affairs advisor. He recently retired as Kendle's senior vice-president of regulatory affairs, a position he had held since 2001. Mr Celeste also worked at the US FDA for 25 years, having last served as director of the office of regional operations, the unit responsible for managing the agency's field force of investigators, analysts, compliance officers and administrative staff.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

SC006426

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel